Specify a stock or a cryptocurrency in the search bar to get a summary
Scandinavian ChemoTech AB Series B
CMOTEC-BScandinavian ChemoTech AB (publ) offers cancer care and pain management solutions in Sweden. The company offers IQWave, an electroporation device, used for electrochemotherapy and treatment of head and neck cancer, squamous cell carcinoma, malignant melanoma, basal cell carcinoma, adenocarcinoma of the breast and salivary gland, hypernephroma, kaposi sarcoma, and transitional cell carcinoma. It also offers Vetiqure for the treatment of superficial tumors in dogs, cats, and horses. The company markets its products through distribution channels and a network of human medicine opinion leaders in the Middle East, Asia, India, and Africa. Scandinavian ChemoTech AB (publ) was incorporated in 2013 and is headquartered in Lund, Sweden. Address: Medicon Village, Lund, Sweden, 223 63
Analytics
WallStreet Target Price
34.21 SEKP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures CMOTEC-B
Dividend Analytics CMOTEC-B
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CMOTEC-B
Stock Valuation CMOTEC-B
Financials CMOTEC-B
Results | 2019 | Dynamics |